PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Anthem BCBSCommercial · Prior Auth · Pharmacy · GA · Pharmacy, Rheumatology, Infectious Disease +5 moreHigh impact

[Georgia] Specialty pharmacy updates

Act
by Nov 15, 2026
Effective date
Dec 1, 2026
Identified
Sep 2, 2026

Summary

Anthem Blue Cross Blue Shield Georgia is implementing new prior authorization and quantity limit requirements for 5 specialty pharmacy drugs effective December 1, 2026, and revising clinical criteria for 11 additional specialty drugs. Billing teams must request prior authorization for affected medications and include NDC codes on claims to expedite processing; previously covered patients may require new authorization for continued medication use.

Get alerts when payers change rules like this one

We check Anthem BCBS and other payers every day and email you when a change matches your specialty and state.

Get Anthem BCBS alertsPolicy Monitoring is free. No card required.

What to do

by Nov 15, 2026 · 7 steps
01Billing team must update systems to require prior authorization submission for all claims dated on or after December 1, 2026 containing HCPCS codes C9399, J3590, or J9999 (specialty pharmacy drugs: Saphnelo, Hepcludex, Decnupaz, Lumvoa, and Trutakna).
02For quantity limit drugs (Saphnelo, Lumvoa, Trutakna), configure system to flag claims exceeding approved quantities.
03Notify all providers that patients currently receiving these medications without prior authorization will need new PA requests submitted before December 1, 2026 for continued coverage.
04Include NDC codes on all specialty pharmacy claims to expedite processing.
05Review the revised clinical criteria (CC-0057, CC-0077, CC-0099, CC-0112, CC-0119, CC-0125, CC-0162, CC-0237, CC-0243, CC-0276, CC-0281) for Krystexxa, Palynziq, Abraxane, Xofigo, Yervoy, Opdivo, Tepezza, Qalsody, Vyjuvek, Tryngolza, and Opdivo Qvantig, as previously approved therapies may now be deemed not medically necessary and require new authorization.
06Claims without required prior authorization will be denied.
07For oncology use of Decnupaz, route prior authorization requests to Carelon Medical Benefits Management, not Anthem's medical specialty drug review team.

Codes mentioned

C9399J3590J9999

Original notice

[Georgia] Specialty pharmacy updates
providernews.anthem.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account